BACE-1, PS-1 and sAPPβ Levels Are Increased in Plasma from Sporadic Inclusion Body Myositis Patients: Surrogate Biomarkers among Inflammatory Myopathies-Reference-Cited by-同舟云学术

BACE-1, PS-1 and sAPPβ Levels Are Increased in Plasma from Sporadic Inclusion Body Myositis Patients: Surrogate Biomarkers among Inflammatory Myopathies

Published:2015-01 Issue:1 Volume:21 Page:817-823
ISSN:1076-1551
Container-title:Molecular Medicine
language:en
Short-container-title:Mol Med

Author:

Catalán-García Marc,Garrabou Glòria,Morén Constanza,Guitart-Mampel Mariona,Gonzalez-Casacuberta Ingrid,Hernando Adriana,Gallego-Escuredo Jose Miquel,Yubero Dèlia,Villarroya Francesc,Montero Raquel,O-Callaghan Albert Selva,Cardellach Francesc,Grau Josep Maria

Publisher

Springer Science and Business Media LLC

Subject

Genetics(clinical),Genetics,Molecular Biology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.2119/molmed.2015.00168.pdf

Reference39 articles.

1. Solorzano GE, Phillips LH 2nd. (2011) Inclusion body myositis: diagnosis, pathogenesis, and treatment options. Rheum. Dis. Clin. North Am. 37:173–83.

2. Griggs RC, et al. (1995) Inclusion body myositis and myopathies. Ann. Neurol. 38:705–13.

3. Needham M, Mastaglia FL. (2007) Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches. Lancet Neurol. 6:620–31.

4. Catalan M, Selva-O’Callaghan A, Grau JM. (2014) Diagnosis and classification of sporadic inclusion body myositis (sIBM). Autoimmun. Rev. 13:363–6.

5. Cox FM, et al. (2011) A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities. Brain. 134:3167–75.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondrial defects in sporadic inclusion body myositis—causes and consequences;Frontiers in Cell and Developmental Biology;2024-05-14

2. Integrated Multi-Omics Analysis for Inferring Molecular Players in Inclusion Body Myositis;Antioxidants;2023-08-19

3. Peripheral Aβ acts as a negative modulator of insulin secretion;Proceedings of the National Academy of Sciences;2022-03-15

4. Mitochondrial dysfunction underlying sporadic inclusion body myositis is ameliorated by the mitochondrial homing drug MA-5;PLOS ONE;2020-12-02

5. Neuropathy in sporadic inclusion body myositis: A multi-modality neurophysiological study;Clinical Neurophysiology;2020-11